[09.11.2011] - Presubmission Meeting @ EMA

IND attended the "presubmission meeting" held at the European Medicines Agency (EMA) on 9 November, as part of the Scientific Advice process, a step that is being carried out in order to validate a regulatory strategy and development plan for IND-006.

IND was represented by Dr. Josep Lluís Falcó (CEO) and by Dr. Francisco Lozano (CSO). In addition to IND representatives, Lidia Cánovas (RPN), Dr. Sophie Domingues (RPN), Dr. Ciriaco Marasciello (Harlan) and Dr. Antonio Pérez (TFS) were also in attendance at the meeting.